Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Anaptysbio (ANAB) Interest Expenses (2016 - 2019)

Anaptysbio filings provide 4 years of Interest Expenses readings, the most recent being $200000.0 for Q4 2019.

  • For the quarter ending Q4 2019, Interest Expenses fell 45.21% year-over-year to $200000.0, compared with a TTM value of $200000.0 through Sep 2020, down 83.42%, and an annual FY2019 reading of $1.0 million, down 36.99% over the prior year.
  • Interest Expenses hit $200000.0 in Q4 2019 for Anaptysbio, down from $240000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $456000.0 in Q4 2017, with the low at $111000.0 in Q4 2016.
  • Median Interest Expenses over the past 4 years was $342500.0 (2018), compared with a mean of $307875.0.
  • The sharpest move saw Interest Expenses soared 310.81% in 2017, then plummeted 45.21% in 2019.
  • Year by year, Interest Expenses stood at $111000.0 in 2016, then surged by 310.81% to $456000.0 in 2017, then decreased by 19.96% to $365000.0 in 2018, then tumbled by 45.21% to $200000.0 in 2019.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $200000.0, $240000.0, and $281000.0 for Q4 2019, Q3 2019, and Q2 2019 respectively.